Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Subauste

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Parasite Immunology|October 18, 2006
Primary immunodeficiencies and susceptibility to parasitic infectionsC S Subauste
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-gammaC S Subauste, M Wessendarp
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1991
Role of gamma interferon in Toxoplasma gondii infectionC S Subauste, J S Remington
Current Opinion in Immunology|August 1, 1993
Immunity to Toxoplasma gondiiC S Subauste, J S Remington
The Journal of Experimental Medicine|December 1, 1992
Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondiiC S Subauste, L Dawson, J S Remington
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1991
Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cellsC S Subauste, A H Koniaris, J S Remington
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
The role of cytokines in toxoplasmosisC A Hunter, C S Subauste, J S Remington
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogenC S Subauste, R de Waal Malefyt, F Fuh
The Journal of Infectious Diseases|May 24, 2001
Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infectionC S Subauste, M Wessendarp, A G Smulian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimerC S Subauste, M Wessendarp, R U Sorensen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Parasite Immunology|October 18, 2006
Primary immunodeficiencies and susceptibility to parasitic infectionsC S Subauste
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-gammaC S Subauste, M Wessendarp
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1991
Role of gamma interferon in Toxoplasma gondii infectionC S Subauste, J S Remington
Current Opinion in Immunology|August 1, 1993
Immunity to Toxoplasma gondiiC S Subauste, J S Remington
The Journal of Experimental Medicine|December 1, 1992
Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondiiC S Subauste, L Dawson, J S Remington
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1991
Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cellsC S Subauste, A H Koniaris, J S Remington
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
The role of cytokines in toxoplasmosisC A Hunter, C S Subauste, J S Remington
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogenC S Subauste, R de Waal Malefyt, F Fuh
The Journal of Infectious Diseases|May 24, 2001
Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infectionC S Subauste, M Wessendarp, A G Smulian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimerC S Subauste, M Wessendarp, R U Sorensen, et al.
Pageof 2